StockData
Incyte Corp logo

Incyte Corp (INCY) stock

INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3086% above fair value
$114.63−1.25 (-1.07%)

Close on Nov 20, 2026Market cap $23.36BP/E 61.0Yield –

Incyte free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Incyte's free cash flow for the twelve months ending Dec 31, 2022 was $892.11M, up 56.9% year over year. For fiscal 2022 it was $892.11M, up 56.9% from the year before. The highest annual figure on record is $892.11M in fiscal 2022.

Annual free cash flow

PeriodPeriod endValueChange
FY2022Dec 31, 2022$892.11M+56.9%
FY2021Dec 31, 2021$568.48M–
FY2020Dec 31, 2020-$311.98M-149.3%
FY2019Dec 31, 2019$632.59M+140.8%
FY2018Dec 31, 2018$262.74M–
FY2017Dec 31, 2017-$204.01M-210.6%
FY2016Dec 31, 2016$184.48M+191.0%
FY2015Dec 31, 2015$63.41M–
FY2014Dec 31, 2014-$1.62M-133.0%
FY2013Dec 31, 2013$4.91M–
FY2012Dec 31, 2012-$97.67M–
FY2011Dec 31, 2011-$165.51M-276.4%
FY2010Dec 31, 2010$93.83M+683.8%
FY2009Dec 31, 2009$11.97M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022$262.39M+224.4%
Q3 FY2022Sep 30, 2022$268.57M+20.5%
Q2 FY2022Jun 30, 2022$162.41M+52.3%
Q1 FY2022Mar 31, 2022$198.74M+25.8%
Q4 FY2021Dec 31, 2021$80.89M+44.7%
Q3 FY2021Sep 30, 2021$222.95M+72.4%
Q2 FY2021Jun 30, 2021$106.64M-52.7%
Q1 FY2021Mar 31, 2021$158.01M–
Q4 FY2020Dec 31, 2020$55.89M-45.4%
Q3 FY2020Sep 30, 2020$129.29M-55.0%
Q2 FY2020Jun 30, 2020$225.52M+113.4%
Q1 FY2020Mar 31, 2020-$722.68M-626.0%
Q4 FY2019Dec 31, 2019$102.30M+74.7%
Q3 FY2019Sep 30, 2019$287.23M+64.8%
Q2 FY2019Jun 30, 2019$105.67M+388.9%
Q1 FY2019Mar 31, 2019$137.40M+1565.8%
Q4 FY2018Dec 31, 2018$58.56M–
Q3 FY2018Sep 30, 2018$174.33M+826.3%
Q2 FY2018Jun 30, 2018$21.61M-75.0%
Q1 FY2018Mar 31, 2018$8.25M–
Q4 FY2017Dec 31, 2017-$114.52M-245.9%
Q3 FY2017Sep 30, 2017$18.82M–
Q2 FY2017Jun 30, 2017$86.30M–
Q1 FY2017Mar 31, 2017-$194.61M–
Q4 FY2016Dec 31, 2016$78.51M–

More Incyte figures

See a number that looks wrong?